Editas Medicine, Inc. — Director's Dealing 2022

Aug 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2022-08-09

Reporting Person: Eaton Bruce (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-09	Common Stock	S	293	$18.5986	Disposed	65128	Direct

Footnotes

F1: Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 6, 2022. The sale does not represent a discretionary trade by the Reporting Person.

F2: This transaction was executed in multiple trades at prices ranging from $18.0525 to $18.61. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.